Total Payments
$664.87
2022 Payments
$183.64
Companies
11
Transactions
30
Medicare Patients
3,041
Medicare Billing
$336,490
Payment Breakdown by Category
Food & Beverage$664.87 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $664.87 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $170.67 | 11 | $0 (2019) |
| Abbott Laboratories | $168.74 | 1 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $84.97 | 4 | $0 (2020) |
| Mylan Specialty L.P. | $47.35 | 3 | $0 (2020) |
| Relypsa, Inc. | $45.66 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $41.94 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $31.40 | 2 | $0 (2022) |
| Vapotherm Inc | $22.94 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $20.07 | 1 | $0 (2019) |
| Alkermes, Inc. | $16.07 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $183.64 | 2 | Abbott Laboratories ($168.74) |
| 2020 | $34.80 | 2 | Sunovion Pharmaceuticals Inc. ($17.93) |
| 2019 | $225.27 | 13 | Sunovion Pharmaceuticals Inc. ($67.04) |
| 2018 | $176.02 | 10 | Novartis Pharmaceuticals Corporation ($94.50) |
| 2017 | $45.14 | 3 | NOVARTIS PHARMACEUTICALS CORPORATION ($19.17) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $168.74 | General |
| Category: Neuromodulation | ||||||
| 06/02/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Respiratory | ||||||
| 01/15/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Respiratory and Allergy | ||||||
| 10/09/2019 | Sunovion Pharmaceuticals Inc. | SEEBRI NEOHALER (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Respiratory and Allergy | ||||||
| 10/02/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2019 | Sunovion Pharmaceuticals Inc. | SEEBRI NEOHALER (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/19/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/14/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Respiratory and Allergy | ||||||
| 04/24/2019 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Respiratory | ||||||
| 04/17/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: CNS | ||||||
| 04/03/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.07 | General |
| Category: Cardiovascular | ||||||
| 03/28/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/21/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/24/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/15/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Hyperkalemia | ||||||
| 06/28/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/30/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2018 | Vapotherm Inc | Precision Flow (Device) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Respiratory | ||||||
| 04/23/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 610 | 1,006 | $448,110 | $105,027 |
| 2022 | 8 | 419 | 640 | $305,015 | $70,793 |
| 2021 | 7 | 995 | 1,194 | $250,193 | $77,287 |
| 2020 | 8 | 1,017 | 1,239 | $268,688 | $83,384 |
Total Patients
3,041
Total Services
4,079
Medicare Billing
$336,490
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 98 | 318 | $258,851 | $51,275 | 19.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 144 | 231 | $70,510 | $20,503 | 29.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 160 | 161 | $40,531 | $13,582 | 33.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 132 | 205 | $37,430 | $12,153 | 32.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 42 | $19,959 | $5,028 | 25.2% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 22 | 24 | $16,872 | $1,538 | 9.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 25 | $3,957 | $948.08 | 24.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 67 | 235 | $193,070 | $39,890 | 20.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 76 | 106 | $29,684 | $8,102 | 27.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 70 | 71 | $16,866 | $5,498 | 32.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 36 | $16,564 | $5,019 | 30.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 74 | 95 | $16,007 | $5,018 | 31.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 27 | 27 | $12,433 | $3,481 | 28.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 58 | 59 | $12,460 | $3,058 | 24.5% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 11 | 11 | $7,931 | $726.44 | 9.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 377 | 399 | $81,990 | $20,665 | 25.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 247 | 363 | $59,329 | $19,545 | 32.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 188 | 195 | $44,145 | $15,801 | 35.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 123 | 176 | $41,314 | $13,848 | 33.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 29 | 30 | $13,536 | $4,229 | 31.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $5,418 | $1,782 | 32.9% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 19 | 19 | $4,461 | $1,417 | 31.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 414 | 438 | $94,840 | $24,032 | 25.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 178 | 325 | $54,104 | $18,313 | 33.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 142 | 144 | $33,972 | $11,935 | 35.1% |
About Dr. Harmohan Singh, M.D
Dr. Harmohan Singh, M.D is a Emergency Medicine healthcare provider based in Kings Mountain, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487608154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harmohan Singh, M.D has received a total of $664.87 in payments from pharmaceutical and medical device companies, with $183.64 received in 2022. These payments were reported across 30 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($664.87).
As a Medicare-enrolled provider, Singh has provided services to 3,041 Medicare beneficiaries, totaling 4,079 services with total Medicare billing of $336,490. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Kings Mountain, NC
- Active Since 05/19/2006
- Last Updated 01/19/2012
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1487608154
Products in Payments
- ENTRESTO (Drug) $170.67
- PROCLAIM (Device) $168.74
- SEEBRI NEOHALER (Drug) $49.01
- Yupelri (Drug) $47.35
- Veltassa (Drug) $45.66
- ZERBAXA (Drug) $41.94
- Precision Flow (Device) $22.94
- ELIQUIS (Drug) $20.07
- BROVANA (Drug) $18.03
- UTIBRON NEOHALER (Drug) $17.93
- LOKELMA (Drug) $16.50
- ARISTADA (Drug) $16.07
- LifeVest (Device) $15.06
- FARXIGA (Drug) $14.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.